Sentiment6 Jul 2020 20:40
Well said Zebbo i Just think it helps to take a step back and look what we are all invested in here.
This company has come a long way last few months and we are now in a new quarter.
End September should be a different entity cash and contract wise.
Then end December another quarter and I’m sure this share price will be way above this level.
With the venn business ticking along nicely and hVIVO hopefully getting the covid challenge study contracts.
Also not forgetting the antibody and antigen testing as well as the data subscription service available hopefully by December.
That’s also goes without the either pending sale or Dividend specie vehicle of imutex.
We just require patience guys and that costs nothing to us.